Citation Impact
Citing Papers
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Ligand-tethered lipid nanoparticles for targeted RNA delivery to treat liver fibrosis
2023 StandoutNobel
A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis C
2003 Standout
Hepatocellular carcinoma
2003 Standout
Classification of acute pancreatitis—2012: revision of the Atlanta classification and definitions by international consensus
2012 Standout
Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections
2005 StandoutNatureNobel
Hepatitis B Virus Infection — Natural History and Clinical Consequences
2004 Standout
Fluid Collections in and Around the Pancreas in Acute Pancreatitis
2011
Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis
1998
New Era of Liver Transplantation for Hepatitis B
2002
Liver fibrosis
2005 Standout
Indocyanine Green Retention Test as a Noninvasive Marker of Portal Hypertension and Esophageal Varices in Compensated Liver Cirrhosis
2013
The Global Impact of Hepatic Fibrosis and End-Stage Liver Disease
2008
Intramuscular hepatitis B immune globulin combined with lamivudine for prophylaxis against hepatitis B recurrence after liver transplantation
1999
A robust cell culture system supporting the complete life cycle of hepatitis B virus
2017 StandoutNobel
Transfusion Strategies for Acute Upper Gastrointestinal Bleeding
2013 Standout
Antifibrotic Agents for Liver Disease
2005
Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C
2005 Standout
Hepatitis B and Hepatitis C Viruses in Liver Transplantation
2004
Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
1998 Standout
Patients With Primary Biliary Cirrhosis React Against A Ubiquitous Xenobiotic–Metabolizing Bacterium
2003
Nonalcoholic Fatty Liver Disease
2002 Standout
Cystic and pseudocystic diseases of the pancreas
1994
Preoperative tumour biopsy does not affect the oncologic course of patients with transplantable HCC
2014
Acute-on chronic liver failure
2012
Upper Digestive Bleeding in Cirrhosis. Post–Therapeutic Outcome and Prognostic Indicators
2003
Randomized clinical trials in Hepatology: Predictors of quality
1999
Adrenocortical dysfunction in liver disease: A systematic review
2012
Hepatocellular carcinoma
2000
The MELD score in patients awaiting liver transplant: Strengths and weaknesses
2010
Drug-Induced Hepatotoxicity
2003 Standout
Prognostic Factors in Noncirrhotic Patients With Splanchnic Vein Thromboses
2007
Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation
1997
Hepatitis B virus infection
2009 Standout
Gastric mucosal responses to intrahepatic portosystemic shunting in patients with cirrhosis
2000
Mechanisms of Actions of Inhaled Anesthetics
2003 Standout
Mutations in Hepatitis B Dna Polymerase Associated With Resistance to Lamivudine Do Not Confer Resistance to Adefovir In Vitro
1998
Liver biopsy†
2008
Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease
2004 Standout
Expanding consensus in portal hypertension
2015 Standout
Lack of difference among terlipressin, somatostatin, and octreotide in the control of acute gastroesophageal variceal hemorrhage
2014
Prognostic value of muscle atrophy in cirrhosis using psoas muscle thickness on computed tomography
2014
Non-Alcoholic Fatty Liver Disease in Older People
2009
Ultrasound-Guided Liver Biopsy for Parenchymal Liver Disease (An Economic Analysis)
1998
Natural and iatrogenic variation in hepatitis B virus
1999
Management of Hepatocellular Carcinoma *
2005 Standout
Antithrombotic Therapy for VTE Disease
2012 Standout
Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
2015 Standout
Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis
2007
Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases
2007 Standout
Non-alcoholic fatty liver disease
2021 Standout
Hepatitis B reactivation after chemotherapy: two decades of clinical research
2008
A randomized controlled trial comparing ligation and sclerotherapy as emergency endoscopic treatment added to somatostatin in acute variceal bleeding
2006
Mechanisms of Hepatic Fibrogenesis
2008 Standout
Treating hepatitis C
2005 StandoutNobel
Multicenter Study of Lamivudine Therapy for Hepatitis B After Liver Transplantation
1999
Chronic hepatitis B
2007 Standout
Treatment of hepatocellular carcinoma in patients with cirrhosis
1997
Hepatic fibrosis plays a central role in the pathogenesis of thrombocytopenia in patients with chronic viral hepatitis
2001
Ymdd Motif in Hepatitis B Virus Dna Polymerase Influences on Replication and Lamivudine Resistance: A Study By In Vitro Full–Length Viral Dna Transfection
1999
Predicting Early Mortality After Acute Variceal Hemorrhage Based on Classification and Regression Tree Analysis
2009
Prevalence and risk factors of non-alcoholic fatty liver disease in potential living liver donors in Korea: A review of 589 consecutive liver biopsies in a single center
2007
Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial
2002 Standout
Liver stiffness measurement predicts severe portal hypertension in patients with HCV‐related cirrhosis†‡
2007
Chronic Active Hepatitis B Exacerbations in Human Immunodeficiency Virus‐Infected Patients Following Development of Resistance to or Withdrawal of Lamivudine
1999
Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis
2013 Standout
Albumin infusion in patients undergoing large-volume paracentesis: A meta-analysis of randomized trials
2011
Myocarditis
2000 Standout
Severe muscle depletion in patients on the liver transplant wait list: Its prevalence and independent prognostic value
2012
Liver stiffness measurement selects patients with cirrhosis at risk of bearing large oesophageal varices
2006
Mechanisms of hepatitis B virus graft reinfection and graft damage after liver transplantation
2004
Magnetic resonance imaging of hepatic fibrosis: Emerging clinical applications
2007
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
2012 Standout
Importance of age in chronic hepatitis C virus infection
1997
Serum markers detect the presence of liver fibrosis: A cohort study
2004
Early administration of somatostatin and efficacy of sclerotherapy in acute oesophageal variceal bleeds: the European Acute Bleeding Oesophageal Variceal Episodes (ABOVE) randomised trial
1997
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection†‡
2006 Standout
Endoscopic treatment versus endoscopic plus pharmacologic treatment for acute variceal bleeding: A meta-analysis
2002
Hepatocellular carcinoma pathogenesis: from genes to environment
2006 Standout
Infection in Solid-Organ Transplant Recipients
2007 Standout
Practices of Liver Biopsy in France: Results of a Prospective Nationwide Survey
2000
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
2001 Standout
Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis C
1998 Standout
Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and re-takeover by wild type after cessation of therapy
1998
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
ROLE OF TACROLIMUS IN THE EVOLUTION OF LIVER TRANSPLANTATION
2004
Liver Biopsy
2001 Standout
Liver transplantation for hepatitis B virus-related liver disease: Indications, prevention of recurrence and results
2003
Scope and Impact of Financial Conflicts of Interest in Biomedical Research
2003 Standout
A Multicenter United States—Canadian Trial to Assess Lamivudine Monotherapy Before and After Liver Transplantation for Chronic Hepatitis B
2001
Revising consensus in portal hypertension: Report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension
2010 Standout
Prevention and Management of Gastroesophageal Varices and Variceal Hemorrhage in Cirrhosis
2007
NF-κB: linking inflammation and immunity to cancer development and progression
2005 Standout
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Ultrasound-Guided Biopsies of Abdominal Organs with an Automatic Biopsy System: A Retrospective Analysis of the Quality of Biopsies and of Hemorrhagic Complications
2000
Effect of Nitrous Oxide on Excitatory and Inhibitory Synaptic Transmission in Hippocampal Cultures
1998
Identification of BMS-200475 as a potent and selective inhibitor of hepatitis B virus
1997
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Early Exposure to Common Anesthetic Agents Causes Widespread Neurodegeneration in the Developing Rat Brain and Persistent Learning Deficits
2003 Standout
Molecular mimicry: Can epitope mimicry induce autoimmune disease?
1997
Treatment of Hepatocellular Carcinoma Associated with Cirrhosis in the Era of Liver Transplantation
1998
Hepascore: An Accurate Validated Predictor of Liver Fibrosis in Chronic Hepatitis C Infection
2005
Predictors of morbidity and mortality after the first episode of upper gastrointestinal bleeding in liver cirrhosis
2000
Optimizing General Management of Acute Variceal Bleeding in Cirrhosis
2014
Management of the hepatitis B virus in the liver transplantation setting: A European and an American perspective
2005
Biology of Oligodendrocyte and Myelin in the Mammalian Central Nervous System
2001 Standout
Molecular mimicry and immune‐mediated diseases
1998
Increased Replicative Fitness Can Lead to Decreased Drug Sensitivity of Hepatitis C Virus
2014 StandoutNobel
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration
2001 Standout
Liver biopsy: complications and risk factors
2000
RNA editing of hepatitis B virus transcripts by activation-induced cytidine deaminase
2013 StandoutNobel
LIVER TRANSPLANTATION FOR CHRONIC VIRAL HEPATITIS
1999
Reported Methodologic Quality and Discrepancies between Large and Small Randomized Trials in Meta-Analyses
2001 Standout
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
Competing risks and prognostic stages of cirrhosis: a 25‐year inception cohort study of 494 patients
2014
Works of AK Burroughs being referenced
Cross-reactivity to lactobacillus delbrueckii/human pyruvate dehydrogenase complex-E2 characterizes primary biliary cirrhosis.
2000
Intravenous albumin infusion is an effective therapy for hyponatraemia in cirrhotic patients with ascites.
1990
Congestive gastropathy and Helicobacter pylori: an endoscopic and morphometric study.
1991
Why portal hypertensive varices bleed and bleed: a hypothesis.
1995
Assessment of therapeutic benefit of antiviral therapy in chronic hepatitis C: is hepatic venous pressure gradient a better end point?
2002
A PILOT STUDY OF IMMUNOSUPPRESSIVE MONOTHERAPY IN LIVER TRANSPLANTATION: TACROLIMUS VERSUS MICROEMULSIFIED CYCLOSPORIN
1999
Definitions, methodology and therapeutic strategies in portal hypertension
1992
Small Hepatocellular Carcinomas in Cirrhotic Explant Livers: Identification by Macroscopic Examination and Lipiodol Localization
1997
Liver disease in Europe
2003
Hepatic phosphorus-31 magnetic resonance spectroscopy in primary biliary cirrhosis and its relation to prognostic models.
1996
Nutritional status and prognosis in cirrhotic patients
2006
A comparison of transjugular and plugged-percutaneous liver biopsy in patients with impaired coagulation
1993
Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis
1996
The effects of glycosaminoglycans on coagulation: a thromboelastographic study
2007
A clinical staging system for cirrhosis: a multicenter cohort study of 1858 patients
2011
Thrombopoietin(TPO) in cirrhosis and after orthotopic liver transplantation (OLT)
1998
488 EFFECT OF INTRA-OPERATIVE METHYLPREDNISOLONE ON POST LIVER TRANSPLANT (LT) INTENSIVE CARE UNIT (ITU) COURSE – FURTHER EVIDENCE FOR THE EXISTENCE OF HEPATO-ADRENAL SYNDROME?
2010
Detection of M2 antibodies in patients with recurrent urinary tract infection using an ELISA and purified PBC specific antigens. Evidence for a molecular mimicry mechanism in the pathogenesis of primary biliary cirrhosis?
1995
Pancreatic pseudocyst causing portal vein thrombosis and pancreatico-pleural fistula.
1990
Therapeutic Benefit of Vaso–Active Drugs for Acute Variceal Bleeding: A Real Pharmacological Effect, or A Side–Effect of Definitions in Trials?
1996
Indications, methods, and outcomes of percutaneous liver biopsy in England and Wales: an audit by the British Society of Gastroenterology and the Royal College of Physicians of London.
1995